Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Shiva Izadi"'
Autor:
Jennifer Schoberer, Shiva Izadi, Carolina Kierein, Ulrike Vavra, Julia König-Beihammer, Valentina Ruocco, Clemens Grünwald-Gruber, Alexandra Castilho, Richard Strasser
Publikováno v:
Frontiers in Plant Science, Vol 14 (2023)
IntroductionThe Golgi apparatus of plants is the central cellular organelle for glycan processing and polysaccharide biosynthesis. These essential processes are catalyzed by a large number of Golgi-resident glycosyltransferases and glycosidases whose
Externí odkaz:
https://doaj.org/article/d51270cf601b46ce9dacb6de0756f601
Autor:
Shiva Izadi, Ulrike Vavra, Stanislav Melnik, Clemens Grünwald-Gruber, Esther Föderl-Höbenreich, Markus Sack, Kurt Zatloukal, Josef Glössl, Eva Stöger, Lukas Mach, Alexandra Castilho, Richard Strasser
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 11 (2023)
SARS-CoV-2 infects human cells via binding of the viral spike glycoprotein to its main cellular receptor, angiotensin-converting enzyme 2 (ACE2). The spike protein-ACE2 receptor interaction is therefore a major target for the development of therapeut
Externí odkaz:
https://doaj.org/article/b00aae2617684bc2bb46c3d926f815b9
Autor:
Pia Gattinger, Shiva Izadi, Clemens Grünwald-Gruber, Somanath Kallolimath, Alexandra Castilho
Publikováno v:
Frontiers in Plant Science, Vol 12 (2021)
The potential therapeutic value of many proteins is ultimately limited by their rapid in vivo clearance. One strategy to limit clearance by metabolism and excretion, and improving the stability of therapeutic proteins, is their fusion to the immunogl
Externí odkaz:
https://doaj.org/article/2c6572a51ae646ebbc0ea9e3afc1887d
Publikováno v:
PLoS ONE, Vol 16, Iss 11, p e0260796 (2021)
Thrombolytic and fibrinolytic therapies are effective treatments to dissolve blood clots in stroke therapy. Thrombolytic drugs activate plasminogen to its cleaved form plasmin, a proteolytic enzyme that breaks the crosslinks between fibrin molecules.
Externí odkaz:
https://doaj.org/article/5ce5eeb1ef3f4c788f4e2492eb9d9abb
Publikováno v:
Journal of Biotechnology. 365:48-53
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7bda01eea4fbeec2c4b0ad97bdeb5bb3
https://doi.org/10.1016/j.jbiotec.2023.02.004
https://doi.org/10.1016/j.jbiotec.2023.02.004
Autor:
Vanessa Monteil, Shiva Izadi, Gerald Wirnsberger, Clemens Grünwald-Gruber, Janine Niederhöfer, Lukas Mach, Richard Strasser, Ali Mirazimi, Jennifer Schwestka, Alexandra Castilho, Eva Stoger, Nikolaus F. Kienzl, Chaitra Hiremath, Elisabeth Laurent, Ulrike Vavra, Johannes Stadlmann
Publikováno v:
Biotechnology Journal
Human angiotensin‐converting enzyme 2 (ACE2) is the primary host cell receptor for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) binding and cell entry. Administration of high concentrations of soluble ACE2 can be utilized as a d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c1c24928f332aa4654964d158232376
http://europepmc.org/articles/PMC7995010
http://europepmc.org/articles/PMC7995010
Publikováno v:
PLoS ONE, Vol 16, Iss 11, p e0260796 (2021)
PLoS ONE
PLoS ONE
Thrombolytic and fibrinolytic therapies are effective treatments to dissolve blood clots in stroke therapy. Thrombolytic drugs activate plasminogen to its cleaved form plasmin, a proteolytic enzyme that breaks the crosslinks between fibrin molecules.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c547ee28fb88680d42789b6725192656
https://doaj.org/article/5ce5eeb1ef3f4c788f4e2492eb9d9abb
https://doaj.org/article/5ce5eeb1ef3f4c788f4e2492eb9d9abb
Autor:
M. Garak-Yaraghi, J. Hasheminia, M. Janghorbani, B. Rafiee-Moghadam, Shiva Izadi, Roya Sherkat
Publikováno v:
Clinical Immunology. 131:S147
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a244b3915570d9e6899956fef410803
https://doi.org/10.1016/j.clim.2009.03.433
https://doi.org/10.1016/j.clim.2009.03.433